Pear Therapeutics, Inc.
PEARQ
Revenue
2.57M
▼-1.52M▼-37.18%
3 Months ChangeAssets
95.13M
▼-24.61M▼-20.55%
3 Months ChangeLiabilities
64.54M
▼-2.95M▼-4.36%
3 Months ChangeFree Cash Flow
-37.21M
▼-15.46M▼-71.08%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2023-04-10
Form 8-K
ID: 0001835567-23-000022
2023-04-07
Form 8-K
ID: 0001835567-23-000020
2023-03-17
Form 8-K
ID: 0001835567-23-000014
2023-02-24
Form 8-K
ID: 0001835567-23-000010
2023-01-03
Form 8-K
ID: 0001628280-23-000009
2022-11-14
Form 10-Q
ID: 0001835567-22-000076
2022-11-14
Form 8-K
ID: 0001835567-22-000073
2022-08-11
Form 10-Q
ID: 0001835567-22-000069
2022-08-11
Form 8-K
ID: 0001835567-22-000066
2022-07-25
Form 8-K
ID: 0001835567-22-000059